VF
PHXM

Virtu Financial’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Virtu Financial’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,003
Closed -$20K – 2257
2023
Q1 		$20K Buy
+2,003
New +$15.5K ﹤0.01% 1246

Other funds holding PHXM

VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Virtu Financial's PHXM Position: Q2 2023 in Review

Virtu Financial sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q2 2023, closing a stake of 2,003 shares — an estimated $20K sold.

Virtu Financial first reported a position in PHXM in Q1 2023 and held it in 1 quarter. The position peaked at $20K in Q1 2023. 8 funds tracked by Wall St. Rank hold PHXM as of Q2 2023.

  • Virtu Financial reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 2,003 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q2 2023, an estimated $20K.
  • Virtu Financial first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q1 2023 and held it in 1 quarter.
  • Virtu Financial's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $20K in Q1 2023.
  • 8 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.